首页 > 最新文献

Journal of Obesity最新文献

英文 中文
Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study. 撤回:英国生物库研究中的肥胖测量和SARS-CoV-2检测阳性的风险。
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-03-18 eCollection Date: 2022-01-01 DOI: 10.1155/2022/9848453
Journal Of Obesity

[This retracts the article DOI: 10.1155/2021/8837319.].

[本文撤回文章DOI: 10.1155/2021/8837319.]。
{"title":"Retracted: Measures of Adiposity and Risk of Testing Positive for SARS-CoV-2 in the UK Biobank Study.","authors":"Journal Of Obesity","doi":"10.1155/2022/9848453","DOIUrl":"10.1155/2022/9848453","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/8837319.].</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2022 ","pages":"9848453"},"PeriodicalIF":3.8,"publicationDate":"2022-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9904113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis. 2000年至2020年中东国家成人肥胖和超重患病率:系统回顾和荟萃分析
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-02-03 eCollection Date: 2022-01-01 DOI: 10.1155/2022/8074837
Hassan Okati-Aliabad, Alireza Ansari-Moghaddam, Shiva Kargar, Neda Jabbari

Background: Obesity has become a significant public health issue worldwide, and it is a major risk factor for many noncommunicable diseases. This systematic review aimed to identify the prevalence of obesity and overweight in the Middle East region and different countries in this region.

Materials and methods: PubMed, Google Scholar, and MEDLINE databases were searched from 2000-2020 to identify relevant studies in the Middle East area. The survey was carried out using combinations of Medical Subject Headings (Mesh) keywords like "body mass index", "obesity", "overweight", "prevalence", "Middle-East", and "Countries in the Middle East area". Analysis of the data was done using STATA-14, and a random-effects model was used to estimate the pooled prevalence.

Results: A total of 101 studies with 698905 participants have been identified that met inclusion criteria for this meta-analysis. The pooled estimates of the prevalence of obesity and overweight in the Middle East area were 21.17 (95% CI: 17.05-26.29) and 33.14 (95% CI: 26.87-40.87), respectively. The findings showed that obesity prevalence increased with age so that the highest prevalence of obesity and overweight was observed in people >40 years old. Obesity prevalence in the Middle East area remained steady between 2000-2006 and 2014-2020 (23%). During these time intervals, the prevalence of overweight decreased from 34.83 (95% CI: 32.40-37.45) to 32.85 (95% CI: 31.39-34.38).

Conclusions: Despite the relative stabilization of the overweight and obesity trend in the Middle East, current interventions to combat the overweight epidemic need to be maintained and strengthened because the prevalence of overweight and obesity in this region is still very high. The prevalence of obesity increases with age so that people over 40 have the highest percentage of obesity and overweight. Therefore, implementing intervention programs to prevent and control obesity and overweight in the Middle East is essential.

背景:肥胖已成为世界范围内一个重要的公共卫生问题,是许多非传染性疾病的主要危险因素。本系统综述旨在确定中东地区和该地区不同国家的肥胖和超重患病率。材料和方法:检索2000-2020年PubMed、谷歌Scholar和MEDLINE数据库,确定中东地区的相关研究。该调查使用了诸如“身体质量指数”、“肥胖”、“超重”、“患病率”、“中东”和“中东地区国家”等医学主题词(Mesh)的组合进行。使用STATA-14对数据进行分析,并使用随机效应模型来估计合并患病率。结果:共有101项研究698905名受试者符合本荟萃分析的纳入标准。中东地区肥胖和超重患病率的汇总估计分别为21.17 (95% CI: 17.05-26.29)和33.14 (95% CI: 26.87-40.87)。研究结果表明,肥胖患病率随着年龄的增长而增加,因此在40岁至40岁的人群中,肥胖和超重的患病率最高。中东地区的肥胖患病率在2000-2006年和2014-2020年期间保持稳定(23%)。在这些时间间隔内,超重患病率从34.83 (95% CI: 32.40-37.45)降至32.85 (95% CI: 31.39-34.38)。结论:尽管中东地区的超重和肥胖趋势相对稳定,但由于该地区的超重和肥胖患病率仍然很高,因此需要维持和加强目前对抗超重流行病的干预措施。肥胖的患病率随着年龄的增长而增加,因此40岁以上的人肥胖和超重的比例最高。因此,在中东地区实施预防和控制肥胖和超重的干预方案至关重要。
{"title":"Prevalence of Obesity and Overweight among Adults in the Middle East Countries from 2000 to 2020: A Systematic Review and Meta-Analysis.","authors":"Hassan Okati-Aliabad, Alireza Ansari-Moghaddam, Shiva Kargar, Neda Jabbari","doi":"10.1155/2022/8074837","DOIUrl":"10.1155/2022/8074837","url":null,"abstract":"<p><strong>Background: </strong>Obesity has become a significant public health issue worldwide, and it is a major risk factor for many noncommunicable diseases. This systematic review aimed to identify the prevalence of obesity and overweight in the Middle East region and different countries in this region.</p><p><strong>Materials and methods: </strong>PubMed, Google Scholar, and MEDLINE databases were searched from 2000-2020 to identify relevant studies in the Middle East area. The survey was carried out using combinations of Medical Subject Headings (Mesh) keywords like \"body mass index\", \"obesity\", \"overweight\", \"prevalence\", \"Middle-East\", and \"Countries in the Middle East area\". Analysis of the data was done using STATA-14, and a random-effects model was used to estimate the pooled prevalence.</p><p><strong>Results: </strong>A total of 101 studies with 698905 participants have been identified that met inclusion criteria for this meta-analysis. The pooled estimates of the prevalence of obesity and overweight in the Middle East area were 21.17 (95% CI: 17.05-26.29) and 33.14 (95% CI: 26.87-40.87), respectively. The findings showed that obesity prevalence increased with age so that the highest prevalence of obesity and overweight was observed in people >40 years old. Obesity prevalence in the Middle East area remained steady between 2000-2006 and 2014-2020 (23%). During these time intervals, the prevalence of overweight decreased from 34.83 (95% CI: 32.40-37.45) to 32.85 (95% CI: 31.39-34.38).</p><p><strong>Conclusions: </strong>Despite the relative stabilization of the overweight and obesity trend in the Middle East, current interventions to combat the overweight epidemic need to be maintained and strengthened because the prevalence of overweight and obesity in this region is still very high. The prevalence of obesity increases with age so that people over 40 have the highest percentage of obesity and overweight. Therefore, implementing intervention programs to prevent and control obesity and overweight in the Middle East is essential.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2022 ","pages":"8074837"},"PeriodicalIF":3.8,"publicationDate":"2022-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831052/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39915405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age-Related Trends in Body Composition among Women Aged 20-80 Years: A Cross-Sectional Study. 20-80岁女性身体成分的年龄相关趋势:一项横断面研究
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-02-02 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4767793
Nirmala Rathnayake, Hasanga Rathnayake, Sarath Lekamwasam

The determinants of body composition are likely to vary geographically due to the diversity of genetic and environmental factors between populations. Age-related trends in body composition in a population help understanding the health issues that are linked with different body compartments. In general, such studies are scarce in the South Asian region and this cross-sectional study examined the age-related trends in body composition in a selected group of healthy women aged 20-80 years in Sri Lanka. The study included randomly selected 784 healthy women aged 20-80 years from the Southern province, Sri Lanka. Women were divided into five age groups: 20-29 years (n = 79), 30-39 years (n = 144), 40-49 years (n = 185), 50-59 years (n = 281), and ≥60 years (n = 85). Total body bone mineral density (TBBMD, g/cm2), total body bone mineral content (TBBMC, g), total body fat mass (TBFM, kg), and total body lean mass (TBLM, kg) were measured with central-type dual-energy X-ray absorptiometry (DXA). Multivariate analysis of variance with Bonferroni post hoc test was performed. The age-related trends of TBBMD and TBBMC were similar with a peak in 40-49-year age group. Between 50 and 59 and ≥60 age categories, TBBMD and TBBMC showed a rapid decline: 16% and 23%, respectively. The rate of TBBMD decline was 0.008 g/cm2 per year after 50 years. TBFM increased by 14% between age categories 20-29 and 40-49 years and remained unchanged after 49 years. TBLM increased by 15% between age groups 20-29 and 40-49 years and then decreased by 13% between age categories 50-59 and ≥60 years. Of the 13% decrease in TBLM after 50 years, 9% loss occurred after 59 years. The trends observed help to understand the occurrence of diseases linked with body composition.

由于种群间遗传和环境因素的多样性,身体组成的决定因素可能在地理上有所不同。人群中与年龄相关的身体组成趋势有助于了解与不同身体部位相关的健康问题。总的来说,这类研究在南亚地区很少,本横断面研究调查了斯里兰卡一组20-80岁健康妇女的身体组成与年龄有关的趋势。该研究包括从斯里兰卡南部省份随机选择的784名年龄在20-80岁之间的健康女性。将女性分为5个年龄组:20-29岁(n = 79)、30-39岁(n = 144)、40-49岁(n = 185)、50-59岁(n = 281)和≥60岁(n = 85)。采用中心型双能x线骨密度仪(DXA)测量全身骨密度(TBBMD, g/cm2)、全身骨密度(TBBMC, g)、全身脂肪质量(TBFM, kg)、全身瘦质量(TBLM, kg)。采用Bonferroni事后检验进行多变量方差分析。TBBMD和TBBMC的年龄相关趋势相似,在40-49岁年龄组达到高峰。在50 ~ 59岁和≥60岁年龄组,TBBMD和TBBMC迅速下降,分别为16%和23%。50年后TBBMD下降速率为每年0.008 g/cm2。TBFM在20-29岁和40-49岁年龄组增加14%,49年后保持不变。TBLM在20-29岁和40-49岁年龄组中增加15%,在50-59岁和≥60岁年龄组中下降13%。50年后TBLM下降13%,59年后下降9%。观察到的趋势有助于了解与身体组成有关的疾病的发生。
{"title":"Age-Related Trends in Body Composition among Women Aged 20-80 Years: A Cross-Sectional Study.","authors":"Nirmala Rathnayake,&nbsp;Hasanga Rathnayake,&nbsp;Sarath Lekamwasam","doi":"10.1155/2022/4767793","DOIUrl":"https://doi.org/10.1155/2022/4767793","url":null,"abstract":"<p><p>The determinants of body composition are likely to vary geographically due to the diversity of genetic and environmental factors between populations. Age-related trends in body composition in a population help understanding the health issues that are linked with different body compartments. In general, such studies are scarce in the South Asian region and this cross-sectional study examined the age-related trends in body composition in a selected group of healthy women aged 20-80 years in Sri Lanka. The study included randomly selected 784 healthy women aged 20-80 years from the Southern province, Sri Lanka. Women were divided into five age groups: 20-29 years (<i>n</i> = 79), 30-39 years (<i>n</i> = 144), 40-49 years (<i>n</i> = 185), 50-59 years (<i>n</i> = 281), and ≥60 years (<i>n</i> = 85). Total body bone mineral density (TBBMD, g/cm<sup>2</sup>), total body bone mineral content (TBBMC, g), total body fat mass (TBFM, kg), and total body lean mass (TBLM, kg) were measured with central-type dual-energy X-ray absorptiometry (DXA). Multivariate analysis of variance with Bonferroni post hoc test was performed. The age-related trends of TBBMD and TBBMC were similar with a peak in 40-49-year age group. Between 50 and 59 and ≥60 age categories, TBBMD and TBBMC showed a rapid decline: 16% and 23%, respectively. The rate of TBBMD decline was 0.008 g/cm<sup>2</sup> per year after 50 years. TBFM increased by 14% between age categories 20-29 and 40-49 years and remained unchanged after 49 years. TBLM increased by 15% between age groups 20-29 and 40-49 years and then decreased by 13% between age categories 50-59 and ≥60 years. Of the 13% decrease in TBLM after 50 years, 9% loss occurred after 59 years. The trends observed help to understand the occurrence of diseases linked with body composition.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":" ","pages":"4767793"},"PeriodicalIF":3.3,"publicationDate":"2022-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39791268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Laparoscopic Banded One Anastomosis Gastric Bypass: A Single-Center Series. 腹腔镜带状胃旁路吻合术:单中心系列。
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-29 eCollection Date: 2022-01-01 DOI: 10.1155/2022/4942052
Michela Campanelli, Emanuela Bianciardi, Domenico Benavoli, Giulia Bagaglini, Giorgio Lisi, Paolo Gentileschi

Introduction: Laparoscopic one anastomosis gastric bypass (LOAGB) is a relatively new procedure for the treatment of morbid obesity and related comorbidities. On average, this procedure results in good postoperative weight loss with a low complication rate. Recent publications suggest that dumping syndrome and weight regain might be reduced by placing a silicone ring over the gastric pouch during the procedure, so called laparoscopic banded one anastomosis gastric bypass (LBOAGB).

Methods: 86 patients undergoing LBOAGB between 2018 and 2020 were enrolled in this retrospective study. Hospital records were used to assess weight loss, comorbidity resolution, and any complications either in the short or medium term.

Results: 54 Female and 32 male patients were included with a mean age of 43 years (25-64), preoperative body mass index of 42 kg/m2 (35-49), and preoperative weight of 114 kg (86-162). Thirty-four patients presented with type 2 diabetes (39.5%), 42 patients (49%) diagnosed with hypertension, 24 presented with OSAS (28%), and 21 (24%) hypercholesterolaemia patients were included. In total, 36 patients were diagnosed with multiple comorbidities. The operative data showed an average operative time of 48 minutes with 3.4% of patients suffering from early (minor) complications and 2.3% with a late (minor) complication. One patient required reoperation due to intra-abdominal bleeding. The median length of hospital stay was 2.5 days. Median follow-up was 18 months (5-36). In that period, no patient required ring removal or conversion to Roux-en-Y gastric bypass surgery. Food intolerance/vomiting was present in 1 patient (1.1%), bile reflux was present in 1 patient (1.1%), and no stomal ulcers were observed. Mean % excess weight loss at 12 and 24 months was 72% and 80%, respectively. Fifty-two out of 86 patients (60%) had a complete resolution of comorbidities. A CONUT score >2 (mild malnutrition) was found in 40% of patients, while a CONUT score 0-1 was found in 60% of patients.

Conclusion: LBOAGB shows promising results in terms of safety and efficacy in the short term. Further prospective studies will be required to evaluate the consistency of the results in the long term.

腹腔镜一次吻合胃旁路术(LOAGB)是治疗病态肥胖及相关合并症的一种相对较新的手术方法。平均而言,该手术的术后体重减轻效果良好,并发症发生率低。最近的出版物表明,通过在手术过程中在胃袋上放置硅胶环,即所谓的腹腔镜单吻合术胃旁路术(LBOAGB),可以减少倾倒综合征和体重反弹。方法:回顾性研究了2018 - 2020年间86例LBOAGB患者。使用医院记录来评估体重减轻、合并症的解决以及短期或中期的任何并发症。结果:女性54例,男性32例,平均年龄43岁(25-64岁),术前体重指数42 kg/m2(35-49),术前体重114 kg(86-162)。其中34例为2型糖尿病(39.5%),42例为高血压(49%),24例为OSAS(28%), 21例为高胆固醇血症(24%)。总共有36名患者被诊断患有多种合并症。手术资料显示平均手术时间为48分钟,3.4%的患者出现早期(轻微)并发症,2.3%的患者出现晚期(轻微)并发症。1例患者因腹内出血需要再次手术。住院时间中位数为2.5天。中位随访时间为18个月(5-36)。在此期间,没有患者需要取环或转Roux-en-Y胃旁路手术。1例(1.1%)患者出现食物不耐受/呕吐,1例(1.1%)患者出现胆汁反流,未观察到口溃疡。12个月和24个月的平均超重率分别为72%和80%。86例患者中有52例(60%)的合并症得到完全解决。40%的患者的CONUT评分>2(轻度营养不良),60%的患者的CONUT评分为0-1。结论:LBOAGB在短期内具有良好的安全性和有效性。需要进一步的前瞻性研究来评估长期结果的一致性。
{"title":"Laparoscopic Banded One Anastomosis Gastric Bypass: A Single-Center Series.","authors":"Michela Campanelli,&nbsp;Emanuela Bianciardi,&nbsp;Domenico Benavoli,&nbsp;Giulia Bagaglini,&nbsp;Giorgio Lisi,&nbsp;Paolo Gentileschi","doi":"10.1155/2022/4942052","DOIUrl":"https://doi.org/10.1155/2022/4942052","url":null,"abstract":"<p><strong>Introduction: </strong>Laparoscopic one anastomosis gastric bypass (LOAGB) is a relatively new procedure for the treatment of morbid obesity and related comorbidities. On average, this procedure results in good postoperative weight loss with a low complication rate. Recent publications suggest that dumping syndrome and weight regain might be reduced by placing a silicone ring over the gastric pouch during the procedure, so called laparoscopic banded one anastomosis gastric bypass (LBOAGB).</p><p><strong>Methods: </strong>86 patients undergoing LBOAGB between 2018 and 2020 were enrolled in this retrospective study. Hospital records were used to assess weight loss, comorbidity resolution, and any complications either in the short or medium term.</p><p><strong>Results: </strong>54 Female and 32 male patients were included with a mean age of 43 years (25-64), preoperative body mass index of 42 kg/m<sup>2</sup> (35-49), and preoperative weight of 114 kg (86-162). Thirty-four patients presented with type 2 diabetes (39.5%), 42 patients (49%) diagnosed with hypertension, 24 presented with OSAS (28%), and 21 (24%) hypercholesterolaemia patients were included. In total, 36 patients were diagnosed with multiple comorbidities. The operative data showed an average operative time of 48 minutes with 3.4% of patients suffering from early (minor) complications and 2.3% with a late (minor) complication. One patient required reoperation due to intra-abdominal bleeding. The median length of hospital stay was 2.5 days. Median follow-up was 18 months (5-36). In that period, no patient required ring removal or conversion to Roux-en-Y gastric bypass surgery. Food intolerance/vomiting was present in 1 patient (1.1%), bile reflux was present in 1 patient (1.1%), and no stomal ulcers were observed. Mean % excess weight loss at 12 and 24 months was 72% and 80%, respectively. Fifty-two out of 86 patients (60%) had a complete resolution of comorbidities. A CONUT score >2 (mild malnutrition) was found in 40% of patients, while a CONUT score 0-1 was found in 60% of patients.</p><p><strong>Conclusion: </strong>LBOAGB shows promising results in terms of safety and efficacy in the short term. Further prospective studies will be required to evaluate the consistency of the results in the long term.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2022 ","pages":"4942052"},"PeriodicalIF":3.3,"publicationDate":"2022-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39898221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
A Case-Control Study of the Association of Leptin Gene Polymorphisms with Plasma Leptin Levels and Obesity in the Kerala Population. 喀拉拉邦人群瘦素基因多态性与血浆瘦素水平和肥胖关系的病例对照研究
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-01 DOI: 10.1155/2022/1040650
Sudharmadevi K Manju, Thottathil R Anilkumar, G Vysakh, Balakumaran K Leena, Vijayalekshmi Lekshminarayan, Pradeep G Kumar, Trivikrama K Shenoy

Background: Over the last few years, the importance of leptin in energy metabolism has been extensively studied in both animal models and in humans. Very few results are available on the association between human leptin gene (LEP) variants and obesity traits in India. We designed this study to analyse the polymorphisms in human leptin gene and the association of sequence variants with obesity among the population in Kerala, South India.

Methods: In this case-control design of 148 study participants, data were collected on socioeconomic aspects and anthropometric measurements. Plasma glucose, insulin, leptin, and lipid profile were measured. Genotyping was done by automated DNA sequencing.

Results: The common Single Nucleotide Polymorphism (SNP) of 5'-UTR of LEP - 2548G/A was found to be present in the study population with "A" variant as dominant allele. A novel synonymous mutation Thr5Thr of exon 2 of LEP was identified in heterozygous form in one subject with morbid obesity with hyperleptinemia. A novel missense mutation Phe17Leu was observed in two subjects with obesity in heterozygous condition. A novel missense mutation Lys36Arg in exon 2 of LEP was observed in one subject with abdominal obesity and decreased serum leptin level.

Conclusion: LEP - 2548G/A at 5'-untranslated region was found to be common with the mutant "A" variant in the study population. SNPs of exons in LEP were found to be rare but associated with morbid obesity and altered levels of serum leptin in the study population in Kerala, India.

背景:在过去的几年里,瘦素在能量代谢中的重要性已经在动物模型和人类中得到了广泛的研究。在印度,很少有关于人类瘦素基因(LEP)变异与肥胖特征之间关系的结果。本研究旨在分析印度南部喀拉拉邦人群瘦素基因多态性及其序列变异与肥胖的关系。方法:在148名研究参与者的病例对照设计中,收集了社会经济方面和人体测量的数据。测定血糖、胰岛素、瘦素和血脂。通过自动DNA测序进行基因分型。结果:LEP - 2548G/A的5′- utr共有单核苷酸多态性(SNP)存在于以“A”变异体为优势等位基因的研究人群中。LEP外显子2的一个新的同义突变Thr5Thr在一名患有病态肥胖和高瘦素血症的受试者中以杂合形式被鉴定出来。在2例肥胖患者杂合状态下发现了一种新的错义突变Phe17Leu。在一名腹部肥胖和血清瘦素水平下降的受试者中,观察到LEP外显子2中新错义突变Lys36Arg。结论:LEP - 2548G/A在研究人群的5′-非翻译区与突变体“A”共同存在。在印度喀拉拉邦的研究人群中,LEP外显子的snp被发现是罕见的,但与病态肥胖和血清瘦素水平改变有关。
{"title":"A Case-Control Study of the Association of Leptin Gene Polymorphisms with Plasma Leptin Levels and Obesity in the Kerala Population.","authors":"Sudharmadevi K Manju,&nbsp;Thottathil R Anilkumar,&nbsp;G Vysakh,&nbsp;Balakumaran K Leena,&nbsp;Vijayalekshmi Lekshminarayan,&nbsp;Pradeep G Kumar,&nbsp;Trivikrama K Shenoy","doi":"10.1155/2022/1040650","DOIUrl":"https://doi.org/10.1155/2022/1040650","url":null,"abstract":"<p><strong>Background: </strong>Over the last few years, the importance of leptin in energy metabolism has been extensively studied in both animal models and in humans. Very few results are available on the association between human leptin gene (<i>LEP</i>) variants and obesity traits in India. We designed this study to analyse the polymorphisms in human leptin gene and the association of sequence variants with obesity among the population in Kerala, South India.</p><p><strong>Methods: </strong>In this case-control design of 148 study participants, data were collected on socioeconomic aspects and anthropometric measurements. Plasma glucose, insulin, leptin, and lipid profile were measured. Genotyping was done by automated DNA sequencing.</p><p><strong>Results: </strong>The common Single Nucleotide Polymorphism (SNP) of 5'-UTR of <i>LEP</i> - 2548G/A was found to be present in the study population with \"A\" variant as dominant allele. A novel synonymous mutation Thr5Thr of exon 2 of <i>LEP</i> was identified in heterozygous form in one subject with morbid obesity with hyperleptinemia. A novel missense mutation Phe17Leu was observed in two subjects with obesity in heterozygous condition. A novel missense mutation Lys36Arg in exon 2 of <i>LEP</i> was observed in one subject with abdominal obesity and decreased serum leptin level.</p><p><strong>Conclusion: </strong><i>LEP</i> - 2548G/A at 5'-untranslated region was found to be common with the mutant \"A\" variant in the study population. SNPs of exons in <i>LEP</i> were found to be rare but associated with morbid obesity and altered levels of serum leptin in the study population in Kerala, India.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2022 ","pages":"1040650"},"PeriodicalIF":3.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10538859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
High Prevalence of Prediabetes and Associated Risk Factors in Urban Areas of Pontianak, Indonesia: A Cross-Sectional Study. 印度尼西亚Pontianak城市地区糖尿病前期患病率高及相关危险因素:一项横断面研究。
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2022-01-01 DOI: 10.1155/2022/4851044
Indah Budiastutik, Martha I Kartasurya, Hertanto W Subagio, Bagoes Widjanarko

Uncontrolled prediabetes can develop into Type 2 Diabetes mellitus (T2DM). The incidence of T2DM among adults in Pontianak, Indonesia was reported remarkably high. Therefore, this study aimed to investigate the risk factors for prediabetes in adults living in urban areas of Pontianak, Indonesia. A cross-sectional study was conducted in 5 subdistricts of Pontianak. A total of 506 adults underwent screening to obtain subjects with fasting blood glucose (FBS) of ≤124 mg/dL and aged >30 years. Blood pressure and body mass index (BMI) were measured. Interview using a structured questionnaire were performed to obtain data on predictor variables (age, sex, education, income, health insurance, tobacco use, history of hypertension, gout, high cholesterol level, frequency of exercise per week, and diabetic education). The prevalence of prediabetes among subjects was significantly high (76.4%). Subjects were predominantly above 40 years, female, had low income, low education level, and had health insurance. About a third of the subjects had a history of hypertension, gout, and high cholesterol level, respectively. The exercise frequency was mostly less than 3 times/week, and the BMI was mainly classified as overweight and obese. The result of spearman's rho correlation showed that age (r = 0.146; p=0.022) and BMI (r = 0.130; p=0.041) significantly correlated with prediabetes incidence. Moreover, the chi-square analysis demonstrated that health insurance ownership (OR = 4.473; 95% CI 1.824-10.972; p ≤ 0.001), history of hypertension (OR = 3.096; 95% CI 1.542-6.218; p=0.001), and history of gout (OR = 2.419; 95% CI 1.148-5.099; p=0.018), were associated with prediabetes incidence. For all these significant risk predictors except BMI, the significant associations were found only among female subjects after specific sex analysis. Moreover, multivariate logistic regression showed that health insurance ownerships (OR = 5.956; 95% CI 2.256-15.661; p ≤ 0.001) and history of hypertension (OR = 3.257; 95% CI 1.451-7.311; p=0.004), and systolic blood pressure (OR = 2.141; 95% CI 1.092-4.196; p=0.027) were the risk factors for prediabetes. It is concluded that the prevalence of prediabetes is probably high especially among urban people in Pontianak, Indonesia. Health insurance ownership and hypertension may have an important role in prediabetes management. The risk factors might be different between male and female.

未控制的糖尿病前期可发展为2型糖尿病(T2DM)。据报道,印尼Pontianak的成人2型糖尿病发病率非常高。因此,本研究旨在调查生活在印度尼西亚Pontianak城市地区的成年人前驱糖尿病的危险因素。横断面研究在Pontianak的5个街道进行。共有506名成年人接受了筛查,以获得空腹血糖(FBS)≤124 mg/dL且年龄>30岁的受试者。测量血压和体重指数(BMI)。采用结构化问卷进行访谈,以获得预测变量(年龄、性别、教育程度、收入、健康保险、吸烟、高血压史、痛风史、高胆固醇水平、每周运动频率和糖尿病教育)的数据。受试者中前驱糖尿病的患病率明显较高(76.4%)。研究对象以40岁以上、低收入、低教育水平、有健康保险的女性为主。大约三分之一的受试者分别有高血压、痛风和高胆固醇病史。运动频次多小于3次/周,BMI以超重和肥胖为主。spearman’s rho相关结果显示,年龄(r = 0.146;p=0.022)和BMI (r = 0.130;P =0.041)与糖尿病前期发病率显著相关。此外,卡方分析表明,健康保险所有权(OR = 4.473;95% ci 1.824-10.972;p≤0.001)、高血压史(OR = 3.096;95% ci 1.542-6.218;p=0.001),痛风病史(OR = 2.419;95% ci 1.148-5.099;P =0.018),与糖尿病前期发病率相关。除BMI外,所有这些显著的风险预测因子在特定的性别分析后,仅在女性受试者中发现显著的关联。此外,多元logistic回归显示,健康保险拥有量(OR = 5.956;95% ci 2.256-15.661;p≤0.001)和高血压史(OR = 3.257;95% ci 1.451-7.311;p=0.004),收缩压(OR = 2.141;95% ci 1.092-4.196;P =0.027)为前驱糖尿病的危险因素。结论是,糖尿病前期的患病率可能很高,特别是在印度尼西亚Pontianak的城市人群中。健康保险所有权和高血压可能在糖尿病前期管理中起重要作用。男性和女性的风险因素可能有所不同。
{"title":"High Prevalence of Prediabetes and Associated Risk Factors in Urban Areas of Pontianak, Indonesia: A Cross-Sectional Study.","authors":"Indah Budiastutik,&nbsp;Martha I Kartasurya,&nbsp;Hertanto W Subagio,&nbsp;Bagoes Widjanarko","doi":"10.1155/2022/4851044","DOIUrl":"https://doi.org/10.1155/2022/4851044","url":null,"abstract":"<p><p>Uncontrolled prediabetes can develop into Type 2 Diabetes mellitus (T2DM). The incidence of T2DM among adults in Pontianak, Indonesia was reported remarkably high. Therefore, this study aimed to investigate the risk factors for prediabetes in adults living in urban areas of Pontianak, Indonesia. A cross-sectional study was conducted in 5 subdistricts of Pontianak. A total of 506 adults underwent screening to obtain subjects with fasting blood glucose (FBS) of ≤124 mg/dL and aged >30 years. Blood pressure and body mass index (BMI) were measured. Interview using a structured questionnaire were performed to obtain data on predictor variables (age, sex, education, income, health insurance, tobacco use, history of hypertension, gout, high cholesterol level, frequency of exercise per week, and diabetic education). The prevalence of prediabetes among subjects was significantly high (76.4%). Subjects were predominantly above 40 years, female, had low income, low education level, and had health insurance. About a third of the subjects had a history of hypertension, gout, and high cholesterol level, respectively. The exercise frequency was mostly less than 3 times/week, and the BMI was mainly classified as overweight and obese. The result of spearman's rho correlation showed that age (<i>r</i> = 0.146; <i>p</i>=0.022) and BMI (<i>r</i> = 0.130; <i>p</i>=0.041) significantly correlated with prediabetes incidence. Moreover, the chi-square analysis demonstrated that health insurance ownership (OR = 4.473; 95% CI 1.824-10.972; <i>p</i> ≤ 0.001), history of hypertension (OR = 3.096; 95% CI 1.542-6.218; <i>p</i>=0.001), and history of gout (OR = 2.419; 95% CI 1.148-5.099; <i>p</i>=0.018), were associated with prediabetes incidence. For all these significant risk predictors except BMI, the significant associations were found only among female subjects after specific sex analysis. Moreover, multivariate logistic regression showed that health insurance ownerships (OR = 5.956; 95% CI 2.256-15.661; <i>p</i> ≤ 0.001) and history of hypertension (OR = 3.257; 95% CI 1.451-7.311; <i>p</i>=0.004), and systolic blood pressure (OR = 2.141; 95% CI 1.092-4.196; <i>p</i>=0.027) were the risk factors for prediabetes. It is concluded that the prevalence of prediabetes is probably high especially among urban people in Pontianak, Indonesia. Health insurance ownership and hypertension may have an important role in prediabetes management. The risk factors might be different between male and female.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2022 ","pages":"4851044"},"PeriodicalIF":3.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10450617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Predictors of Weight Loss and Weight Gain in Weight Management Patients during the COVID-19 Pandemic. COVID-19大流行期间体重管理患者体重减轻和体重增加的预测因素
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2021-12-17 eCollection Date: 2021-01-01 DOI: 10.1155/2021/4881430
Jennifer L Kuk, Rebecca A G Christensen, Elham Kamran Samani, Sean Wharton

Objective: To examine the associations between patient struggles, health, and weight management changes during the COVID-19 pandemic.

Methods: 585 patients attending a publicly funded clinical weight management program responded to an electronic survey.

Results: Over half of the patients reported worsened overall health, mental health, physical activity, or diet during the pandemic. Approximately 30% of patients lost ≥3% of their body weight and 21% gained ≥3% of their body weight between March and July of the pandemic. Reports of social isolation was associated with increased odds for weight loss in women (OR = 2.0, 1.2-3.3), while low motivation (OR = 1.9, 1.0-3.7), depression (OR = 2.5, 1.0-6.3), and struggles with carbohydrate intake (OR = 2.1, 1.0-4.3) were associated with weight gain. Cooking more at home/eating less take out was associated with increased likelihood of weight loss (OR = 2.1, 1.1-3.9) and lower odds for weight gain (OR = 0.2, 0.1 to 0.97). Working from home was not associated with weight loss or weight gain (P > 0.6).

Conclusion: The COVID-19 pandemic is associated with certain factors that may facilitate weight loss and other factors that promote weight gain. Thus, depending on the patient experience during the pandemic, prevention of weight gain may be more appropriate than weight loss.

目的:探讨COVID-19大流行期间患者挣扎、健康和体重管理变化之间的关系。方法:585名参加公费临床体重管理项目的患者填写了一份电子调查问卷。结果:超过一半的患者报告在大流行期间整体健康、心理健康、身体活动或饮食恶化。在大流行的3月至7月期间,约30%的患者体重减轻≥3%,21%的患者体重增加≥3%。社会孤立的报告与女性体重减轻的几率增加有关(OR = 2.0, 1.2-3.3),而低动机(OR = 1.9, 1.0-3.7)、抑郁(OR = 2.5, 1.0-6.3)和努力摄入碳水化合物(OR = 2.1, 1.0-4.3)与体重增加有关。多在家做饭/少吃外卖与体重减轻的可能性增加(OR = 2.1, 1.1-3.9)和体重增加的可能性较低(OR = 0.2, 0.1至0.97)相关。在家工作与体重减轻或增加无关(P > 0.6)。结论:新冠肺炎大流行与某些可能促进体重减轻的因素和其他可能促进体重增加的因素有关。因此,根据大流行期间患者的经验,预防体重增加可能比减肥更合适。
{"title":"Predictors of Weight Loss and Weight Gain in Weight Management Patients during the COVID-19 Pandemic.","authors":"Jennifer L Kuk,&nbsp;Rebecca A G Christensen,&nbsp;Elham Kamran Samani,&nbsp;Sean Wharton","doi":"10.1155/2021/4881430","DOIUrl":"https://doi.org/10.1155/2021/4881430","url":null,"abstract":"<p><strong>Objective: </strong>To examine the associations between patient struggles, health, and weight management changes during the COVID-19 pandemic.</p><p><strong>Methods: </strong>585 patients attending a publicly funded clinical weight management program responded to an electronic survey.</p><p><strong>Results: </strong>Over half of the patients reported worsened overall health, mental health, physical activity, or diet during the pandemic. Approximately 30% of patients lost ≥3% of their body weight and 21% gained ≥3% of their body weight between March and July of the pandemic. Reports of social isolation was associated with increased odds for weight loss in women (OR = 2.0, 1.2-3.3), while low motivation (OR = 1.9, 1.0-3.7), depression (OR = 2.5, 1.0-6.3), and struggles with carbohydrate intake (OR = 2.1, 1.0-4.3) were associated with weight gain. Cooking more at home/eating less take out was associated with increased likelihood of weight loss (OR = 2.1, 1.1-3.9) and lower odds for weight gain (OR = 0.2, 0.1 to 0.97). Working from home was not associated with weight loss or weight gain (<i>P</i> > 0.6).</p><p><strong>Conclusion: </strong>The COVID-19 pandemic is associated with certain factors that may facilitate weight loss and other factors that promote weight gain. Thus, depending on the patient experience during the pandemic, prevention of weight gain may be more appropriate than weight loss.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":" ","pages":"4881430"},"PeriodicalIF":3.3,"publicationDate":"2021-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39625829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The Value of Serum Adiponectin in Osteoporotic Women: Does Weight Have an Effect? 骨质疏松症妇女血清脂联素的价值:体重有影响吗?
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2021-11-09 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5325813
Ali B Roomi, Wassan Nori, Saad H Al-Badry

Osteoporosis (OP) has been observed to have a deleterious effect on postmenopausal women's life quality by increasing the risk of fragility fractures. The current research was adopted to verify the role of serum adiponectin, a cytokine released by adipose tissue, as a marker for OP across different body mass index groups, for a better understanding of fatty tissue role in OP. A case-control study recruited 210 eligible postmenopausal women and subgrouped into three groups based on their DEXA scan results: osteoporotic group, osteopenia group, and healthy controls; each includes 70 patients. Three datasets were collected: anthropometric, age, menopause duration, weight, height, body mass index (BMI), waist circumference, and fat percentage. Radiological examination estimated the bone mineral density (BMD) for the femoral neck and lumbar spines with their respective T-score. From blood, we measured alkaline phosphatase and calcium by a spectrophotometer and serum adiponectin, phosphate, CTX, and PICP by ELIZA. Total BMD, T-score, serum phosphate, and PICP were significantly higher among healthy controls. Serum adiponectin, CTX, and ALP scored higher levels among OP cases. A strong inverse relationship was proved between serum adiponectin and T-score in osteoporotic and osteopenia groups (-0.427, -0.301). A strong negative relationship was found between serum adiponectin and total BMD in healthy controls (-0.204). All correlations were statistically significant, P value <0.001. Serum adiponectin can be a valuable marker for reduced bone mineral density among the general populace, irrespective of the body mass index. Further research is warranted to explore therapeutic and preventive applications for this adipocytokine.

骨质疏松症(OP)已被观察到通过增加脆性骨折的风险对绝经后妇女的生活质量产生有害影响。本研究旨在验证血清脂联素(一种由脂肪组织释放的细胞因子)在不同体重指数组中作为OP标志物的作用,以便更好地了解脂肪组织在OP中的作用。一项病例对照研究招募了210名符合条件的绝经后妇女,并根据DEXA扫描结果将其分为三组:骨质疏松组、骨质减少组和健康对照组;每组包括70名患者。收集了三个数据集:人体测量、年龄、更年期持续时间、体重、身高、体重指数(BMI)、腰围和脂肪百分比。放射学检查估计股骨颈和腰椎的骨密度(BMD)及其各自的t评分。从血液中,我们用分光光度计测定碱性磷酸酶和钙,用elisa测定血清脂联素、磷酸盐、CTX和PICP。在健康对照组中,总骨密度、t评分、血清磷酸盐和PICP显著升高。OP患者血清脂联素、CTX和ALP水平较高。骨质疏松和骨质减少组血清脂联素与t -评分呈显著负相关(-0.427,-0.301)。在健康对照组中,血清脂联素与总骨密度呈显著负相关(-0.204)。所有相关性均有统计学意义,P值
{"title":"The Value of Serum Adiponectin in Osteoporotic Women: Does Weight Have an Effect?","authors":"Ali B Roomi,&nbsp;Wassan Nori,&nbsp;Saad H Al-Badry","doi":"10.1155/2021/5325813","DOIUrl":"https://doi.org/10.1155/2021/5325813","url":null,"abstract":"<p><p>Osteoporosis (OP) has been observed to have a deleterious effect on postmenopausal women's life quality by increasing the risk of fragility fractures. The current research was adopted to verify the role of serum adiponectin, a cytokine released by adipose tissue, as a marker for OP across different body mass index groups, for a better understanding of fatty tissue role in OP. A case-control study recruited 210 eligible postmenopausal women and subgrouped into three groups based on their DEXA scan results: osteoporotic group, osteopenia group, and healthy controls; each includes 70 patients. Three datasets were collected: anthropometric, age, menopause duration, weight, height, body mass index (BMI), waist circumference, and fat percentage. Radiological examination estimated the bone mineral density (BMD) for the femoral neck and lumbar spines with their respective T-score. From blood, we measured alkaline phosphatase and calcium by a spectrophotometer and serum adiponectin, phosphate, CTX, and PICP by ELIZA. Total BMD, T-score, serum phosphate, and PICP were significantly higher among healthy controls. Serum adiponectin, CTX, and ALP scored higher levels among OP cases. A strong inverse relationship was proved between serum adiponectin and T-score in osteoporotic and osteopenia groups (-0.427, -0.301). A strong negative relationship was found between serum adiponectin and total BMD in healthy controls (-0.204). All correlations were statistically significant, <i>P</i> value <0.001. Serum adiponectin can be a valuable marker for reduced bone mineral density among the general populace, irrespective of the body mass index. Further research is warranted to explore therapeutic and preventive applications for this adipocytokine.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":" ","pages":"5325813"},"PeriodicalIF":3.3,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39638207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
The Effect of Bariatric Surgery Volume on General Surgery Outcomes for Morbidly Obese Patients. 减肥手术量对病态肥胖患者一般手术结果的影响。
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2021-10-31 eCollection Date: 2021-01-01 DOI: 10.1155/2021/8945091
Katheryn Hope Wilkinson, Ruizhe Wu, Aniko Szabo, Rana Higgins, Jon Gould, Tammy Kindel

Introduction: Bariatric surgery performed at high volume centers decreases length of stay, cost, and morbidity and mortality. The effect of a high volume of bariatric surgery procedures on outcomes may extend not just to bariatric surgery but to any general surgical procedure in morbidly obese patients. We hypothesized that patients with morbid obesity (body mass index >40 kg/m2) undergoing common, nonbariatric general surgery would have decreased morbidity and mortality at centers performing high volumes of bariatric surgery.

Methods: The 2016 National Inpatient Sample (NIS) was used to identify the number of laparoscopic gastric bypass and sleeve gastrectomy performed at each hospital. Hospitals were classified as high volume bariatric hospitals (HVBH) ≥10 reported cases (50 actual)/year or low volume bariatric hospitals (LVBH) <10 reported cases (50 actual)/year, as NIS reports a 20% sample of actual cases. Patients with morbid obesity undergoing laparoscopic or open appendectomy, cholecystectomy, or ventral hernia repair were included for analysis. Propensity scores were developed based on available demographics, comorbidities, and hospital procedure volume. Postoperative complications during the index hospital admission, determined by ICD-10 code, were compared using inverse propensity weights. Differences were considered significant with a p value of <0.05.

Results: The total number of general surgery patient cases analyzed was 14,028 from 2,482 hospitals, representing 70,140 admissions. The cohort of patients undergoing operations treated at HVBH were younger (p=0.03) with higher rates of COPD (p=0.04). Patients at LVBH had higher rates of nicotine dependence (p=0.0001) and obstructive sleep apnea (p < 0.001). On propensity-weighted analysis adjusting for preoperative comorbidities and hospital procedure volume, there were significantly higher rates of multiple postprocedure complications at LVBH, specifically, postprocedure respiratory failure for patients undergoing elective laparoscopic cholecystectomy, elective ventral hernia repair with mesh and appendectomy.

Conclusion: Patients with morbid obesity may have an advantage in having general surgery procedures at HVBH. HVBH may have a volume-outcomes relationship where the hospital and staff familiarity with the management principles required to minimize the postoperative risk associated with morbid obesity and improve patient outcomes.

简介:在大容量中心进行的减肥手术减少了住院时间、费用、发病率和死亡率。大量减肥手术对结果的影响可能不仅延伸到减肥手术,而且延伸到任何病态肥胖患者的普通外科手术。我们假设患有病态肥胖(体重指数>40 kg/m2)的患者在接受普通的、非减肥的普通手术后,在开展大量减肥手术的中心会降低发病率和死亡率。方法:采用2016年全国住院患者样本(NIS)统计各医院腹腔镜胃旁路术和袖式胃切除术的数量。将医院分为高容量减肥医院(HVBH)≥10例(实际50例)/年或低容量减肥医院(LVBH)。结果:分析的普外科患者病例总数为14,028例,来自2,482家医院,代表70,140人次。在HVBH接受手术治疗的患者队列更年轻(p=0.03), COPD发生率更高(p=0.04)。LVBH组患者尼古丁依赖(p=0.0001)和阻塞性睡眠呼吸暂停(p < 0.001)的发生率较高。在调整术前合并症和医院手术量的倾向加权分析中,LVBH的多种术后并发症的发生率明显更高,特别是接受择期腹腔镜胆囊切除术、择期腹疝补片修复术和阑尾切除术的患者术后呼吸衰竭。结论:病态肥胖患者在HVBH进行普通外科手术可能具有优势。HVBH可能与数量-结果有关,即医院和工作人员对减少与病态肥胖相关的术后风险和改善患者预后所需的管理原则的熟悉程度。
{"title":"The Effect of Bariatric Surgery Volume on General Surgery Outcomes for Morbidly Obese Patients.","authors":"Katheryn Hope Wilkinson,&nbsp;Ruizhe Wu,&nbsp;Aniko Szabo,&nbsp;Rana Higgins,&nbsp;Jon Gould,&nbsp;Tammy Kindel","doi":"10.1155/2021/8945091","DOIUrl":"https://doi.org/10.1155/2021/8945091","url":null,"abstract":"<p><strong>Introduction: </strong>Bariatric surgery performed at high volume centers decreases length of stay, cost, and morbidity and mortality. The effect of a high volume of bariatric surgery procedures on outcomes may extend not just to bariatric surgery but to any general surgical procedure in morbidly obese patients. We hypothesized that patients with morbid obesity (body mass index >40 kg/m<sup>2</sup>) undergoing common, nonbariatric general surgery would have decreased morbidity and mortality at centers performing high volumes of bariatric surgery.</p><p><strong>Methods: </strong>The 2016 National Inpatient Sample (NIS) was used to identify the number of laparoscopic gastric bypass and sleeve gastrectomy performed at each hospital. Hospitals were classified as high volume bariatric hospitals (HVBH) ≥10 reported cases (50 actual)/year or low volume bariatric hospitals (LVBH) <10 reported cases (50 actual)/year, as NIS reports a 20% sample of actual cases. Patients with morbid obesity undergoing laparoscopic or open appendectomy, cholecystectomy, or ventral hernia repair were included for analysis. Propensity scores were developed based on available demographics, comorbidities, and hospital procedure volume. Postoperative complications during the index hospital admission, determined by ICD-10 code, were compared using inverse propensity weights. Differences were considered significant with a <i>p</i> value of <0.05.</p><p><strong>Results: </strong>The total number of general surgery patient cases analyzed was 14,028 from 2,482 hospitals, representing 70,140 admissions. The cohort of patients undergoing operations treated at HVBH were younger (<i>p</i>=0.03) with higher rates of COPD (<i>p</i>=0.04). Patients at LVBH had higher rates of nicotine dependence (<i>p</i>=0.0001) and obstructive sleep apnea (<i>p</i> < 0.001). On propensity-weighted analysis adjusting for preoperative comorbidities and hospital procedure volume, there were significantly higher rates of multiple postprocedure complications at LVBH, specifically, postprocedure respiratory failure for patients undergoing elective laparoscopic cholecystectomy, elective ventral hernia repair with mesh and appendectomy.</p><p><strong>Conclusion: </strong>Patients with morbid obesity may have an advantage in having general surgery procedures at HVBH. HVBH may have a volume-outcomes relationship where the hospital and staff familiarity with the management principles required to minimize the postoperative risk associated with morbid obesity and improve patient outcomes.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":" ","pages":"8945091"},"PeriodicalIF":3.3,"publicationDate":"2021-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39711868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
10-Year Changes in Adiposity in Cameroon School-Age Children: Evidence for Increasing Central Adiposity and Higher Adiposity Levels in Tallest-for-Age Children. 喀麦隆学龄儿童肥胖的10年变化:中枢性肥胖增加和年龄最高儿童肥胖水平升高的证据。
IF 3.3 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2021-10-15 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6866911
Lifoter K Navti, Brice U S Foudjo

Objective: To examine changes in measures of adiposity and determine the prevalence of excess adiposity in relation to height in school children between 2010 and 2020.

Methods: 5-12-year-old urban school-age children participated in two cross-sectional surveys in 2010 (n = 1274) and 2020 (n = 1550). Standard procedures were used for anthropometric measurements. Changes in BMI, waist circumference (WC), and waist-to-height ratio (WHtR) and the corresponding proportions of children with excess adiposity were analyzed and adjusted for design variables (class and school type) and age. Children were classified according to quartiles of height z-score and prevalence of excess adiposity estimated across each quartile.

Results: There was a 2.4% and 3.3% increase in adjusted mean BMI and WC, respectively, between 2010 and 2020. The prevalence of central overweight/obesity (WC) and WHtR ≥ 0.5 increased by 7.3% (X 2 = 27.151, p < 0.001) and 5.3% (X 2 = 26.117, p < 0.001), respectively, between the two surveys except BMI overweight/obesity. The odds of excess adiposity significantly increased in 2020 for central overweight/obesity (WC) (OR 2.8, 95% CI 2.0-3.6) and WHtR ≥ 0.5 (OR 1.8, 95% CI 1.3-2.4) and not for BMI overweight/obesity (OR 1.3, 95% CI 0.8-1.7). The prevalence of BMI overweight/obesity significantly increased from 33% in 2010 to 51.5% in 2020 in the fourth quartile of height z-score (X 2 = 19.198, p < 0.001). Similarly, the prevalence of central overweight/obesity (WC) significantly increased from 23.5% in 2010 to 42.4% in 2020 in the fourth quartile of height z-score (X 2 = 18.733, p < 0.001).

Conclusion: Central overweight/obesity has increased more than BMI overweight/obesity over the last decade. Children with a higher height-for-age tend to accumulate more adiposity. Objective monitoring of adiposity levels and height of children is needed in future to identify groups for targeted intervention and prevention of chronic diseases.

目的:研究肥胖症测量指标的变化,并确定2010年至2020年间学龄儿童中与身高相关的过度肥胖患病率。方法:2010年(n = 1274)和2020年(n = 1550)对5-12岁城市学龄儿童进行两次横断面调查。人体测量采用标准程序。分析超重儿童BMI、腰围(WC)、腰高比(WHtR)及相应比例的变化,并根据设计变量(班级、学校类型)和年龄进行调整。根据身高z分数的四分位数和每个四分位数估计的过度肥胖患病率对儿童进行分类。结果:2010年至2020年间,调整后的平均BMI和WC分别增加了2.4%和3.3%。除BMI超重/肥胖外,中心性超重/肥胖(WC)患病率和WHtR≥0.5患病率分别增加了7.3% (x2 = 27.151, p < 0.001)和5.3% (x2 = 26.117, p < 0.001)。到2020年,中心性超重/肥胖(WC) (OR 2.8, 95% CI 2.0-3.6)和WHtR≥0.5 (OR 1.8, 95% CI 1.3-2.4)的过度肥胖几率显著增加,而BMI超重/肥胖(OR 1.3, 95% CI 0.8-1.7)没有增加。BMI超重/肥胖患病率从2010年的33%上升到2020年的51.5% (x2 = 19.198, p < 0.001)。同样,在身高z分数的第四个四分位数中,中心超重/肥胖(WC)的患病率从2010年的23.5%显著增加到2020年的42.4% (x2 = 18.733, p < 0.001)。结论:在过去十年中,中枢性超重/肥胖比BMI超重/肥胖增加得更多。身高与年龄之比较高的儿童往往会积累更多的脂肪。未来需要对儿童的肥胖水平和身高进行客观监测,以确定有针对性的干预和预防慢性疾病的人群。
{"title":"10-Year Changes in Adiposity in Cameroon School-Age Children: Evidence for Increasing Central Adiposity and Higher Adiposity Levels in Tallest-for-Age Children.","authors":"Lifoter K Navti,&nbsp;Brice U S Foudjo","doi":"10.1155/2021/6866911","DOIUrl":"https://doi.org/10.1155/2021/6866911","url":null,"abstract":"<p><strong>Objective: </strong>To examine changes in measures of adiposity and determine the prevalence of excess adiposity in relation to height in school children between 2010 and 2020.</p><p><strong>Methods: </strong>5-12-year-old urban school-age children participated in two cross-sectional surveys in 2010 (<i>n</i> = 1274) and 2020 (<i>n</i> = 1550). Standard procedures were used for anthropometric measurements. Changes in BMI, waist circumference (WC), and waist-to-height ratio (WHtR) and the corresponding proportions of children with excess adiposity were analyzed and adjusted for design variables (class and school type) and age. Children were classified according to quartiles of height z-score and prevalence of excess adiposity estimated across each quartile.</p><p><strong>Results: </strong>There was a 2.4% and 3.3% increase in adjusted mean BMI and WC, respectively, between 2010 and 2020. The prevalence of central overweight/obesity (WC) and WHtR ≥ 0.5 increased by 7.3% (<i>X</i> <sup>2</sup> = 27.151, <i>p</i> < 0.001) and 5.3% (<i>X</i> <sup>2</sup> = 26.117, <i>p</i> < 0.001), respectively, between the two surveys except BMI overweight/obesity. The odds of excess adiposity significantly increased in 2020 for central overweight/obesity (WC) (OR 2.8, 95% CI 2.0-3.6) and WHtR ≥ 0.5 (OR 1.8, 95% CI 1.3-2.4) and not for BMI overweight/obesity (OR 1.3, 95% CI 0.8-1.7). The prevalence of BMI overweight/obesity significantly increased from 33% in 2010 to 51.5% in 2020 in the fourth quartile of height z-score (<i>X</i> <sup>2</sup> = 19.198, <i>p</i> < 0.001). Similarly, the prevalence of central overweight/obesity (WC) significantly increased from 23.5% in 2010 to 42.4% in 2020 in the fourth quartile of height z-score (<i>X</i> <sup>2</sup> = 18.733, <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Central overweight/obesity has increased more than BMI overweight/obesity over the last decade. Children with a higher height-for-age tend to accumulate more adiposity. Objective monitoring of adiposity levels and height of children is needed in future to identify groups for targeted intervention and prevention of chronic diseases.</p>","PeriodicalId":16628,"journal":{"name":"Journal of Obesity","volume":"2021 ","pages":"6866911"},"PeriodicalIF":3.3,"publicationDate":"2021-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39552456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Journal of Obesity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1